ADMA Biologics director proposes $137K share sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
ADMA Biologics, Inc. (ADMA) director Lawrence P. Guiheen reported a proposed sale of 10,000 common shares, with an aggregate market value of $136,800 and an approximate sale date of November 16, 2026. Guiheen acquired the shares by exercising stock options granted February 14, 2017, with cash listed as the payment method.
Key Figures
Key Terms
Aggregate Market Value financial
stock options financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.